{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T03:53:13Z","timestamp":1785037993205,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1124\/dmd.119.088922","type":"journal-article","created":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T19:05:32Z","timestamp":1570129532000},"page":"1433-1442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo"],"prefix":"10.1016","volume":"47","author":[{"given":"Congrong","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Tep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9505-333X","authenticated-orcid":false,"given":"Yurong","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.119.088922_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/15376511003690307","article-title":"The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies","volume":"20","author":"Amacher","year":"2010","journal-title":"Toxicol Mech Methods"},{"key":"10.1124\/dmd.119.088922_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clpt.2005.04.007","article-title":"Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites","volume":"78","author":"Backman","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.088922_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3389\/fphar.2016.00111","article-title":"Rifampin regulation of drug transporters gene expression and the association of microRNAs in human hepatocytes","volume":"7","author":"Benson","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1124\/dmd.119.088922_bib4","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/cpt.1216","article-title":"Clinical probes and endogenous biomarkers as substrates for transporter drug-drug interaction evaluation: perspectives from the International Transporter Consortium","volume":"104","author":"Chu","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.088922_bib5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1124\/dmd.107.016089","article-title":"Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions","volume":"35","author":"Dixit","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088922_bib6","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0002-9440(10)64794-3","article-title":"The effect of rifampin treatment on intestinal expression of human MRP transporters","volume":"157","author":"Fromm","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1124\/dmd.119.088922_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/dmd.119.088922_bib8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI6663","article-title":"The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin","volume":"104","author":"Greiner","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1124\/dmd.119.088922_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.119.088922_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4062\/biomolther.2016.153","article-title":"Bosentan and rifampin interactions modulate influx transporter and cytochrome P450 expression and activities in primary human hepatocytes","volume":"25","author":"Han","year":"2017","journal-title":"Biomol Ther (Seoul)"},{"key":"10.1124\/dmd.119.088922_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/clpt.2013.74","article-title":"Emerging transporters of clinical importance: an update from the International Transporter Consortium","volume":"94","author":"Hillgren","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.088922_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0968-0004(92)90489-V","article-title":"The ATP-dependent glutathione S-conjugate export pump","volume":"17","author":"Ishikawa","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/dmd.119.088922_bib13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1124\/dmd.106.010033","article-title":"Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes","volume":"34","author":"Jigorel","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088922_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1476-5381.2009.00430.x","article-title":"Impact of OATP transporters on pharmacokinetics","volume":"158","author":"Kalliokoski","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.119.088922_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects","volume":"65","author":"K\u00f6nig","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1124\/dmd.119.088922_bib16","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1067\/mcp.2000.111414","article-title":"Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations","volume":"68","author":"Kyrklund","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.088922_bib17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1046\/j.1365-2125.2003.01972.x","article-title":"Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects","volume":"57","author":"Kyrklund","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.088922_bib18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2174\/13816128113199990467","article-title":"Beyond the ITC white paper: emerging sciences in drug transporters and opportunities for drug development","volume":"20","author":"Lai","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1124\/dmd.119.088922_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/jpet.116.234914","article-title":"Coproporphyrins in plasma and urine can be appropriate clinical biomarkers to recapitulate drug-drug interactions mediated by organic anion transporting polypeptide inhibition","volume":"358","author":"Lai","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.088922_bib20","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/mp900044x","article-title":"Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes","volume":"6","author":"Li","year":"2009","journal-title":"Mol Pharm"},{"key":"10.1124\/dmd.119.088922_bib21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1124\/dmd.119.088922_bib22","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/cpt.1073","article-title":"Cytochrome P450 3A induction predicts P-glycoprotein induction; part 1: establishing induction relationships using ascending dose rifampin","volume":"104","author":"Lutz","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.119.088922_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/dmd.119.088922_bib24","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/hep.23876","article-title":"Liver X receptor \u03b1 and farnesoid X receptor are major transcriptional regulators of OATP1B1","volume":"52","author":"Meyer Zu Schwabedissen","year":"2010","journal-title":"Hepatology"},{"key":"10.1124\/dmd.119.088922_bib25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1098-2744(200011)29:3<170::AID-MC6>3.0.CO;2-W","article-title":"Role of multidrug-resistance protein 2 in glutathione S-transferase P1-1-mediated resistance to 4-nitroquinoline 1-oxide toxicities in HepG2 cells","volume":"29","author":"Morrow","year":"2000","journal-title":"Mol Carcinog"},{"key":"10.1124\/dmd.119.088922_bib26","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1124\/dmd.115.065946","article-title":"Rosuvastatin liver partitioning in cynomolgus monkeys: measurement in vivo and prediction using in vitro monkey hepatocyte uptake","volume":"43","author":"Morse","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088922_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/00498254.2017.1353163","article-title":"Induction of human cytochrome P450 3A4 by the irreversible myeloperoxidase inactivator PF-06282999 is mediated by the pregnane X receptor","volume":"48","author":"Moscovitz","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.119.088922_bib28","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.3748\/wjg.14.7068","article-title":"Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents","volume":"14","author":"Mottino","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1124\/dmd.119.088922_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2003.01884.x","article-title":"Effect of rifampicin on the pharmacokinetics and pharmacodynamics of nateglinide in healthy subjects","volume":"56","author":"Niemi","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.119.088922_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1248\/yakushi.122.339","article-title":"Evaluation of gene induction of drug-metabolizing enzymes and transporters in primary culture of human hepatocytes using high-sensitivity real-time reverse transcription PCR","volume":"122","author":"Nishimura","year":"2002","journal-title":"Yakugaku Zasshi"},{"key":"10.1124\/dmd.119.088922_bib31","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1124\/dmd.111.039206","article-title":"Oral absorption of clarithromycin is nearly abolished by chronic comedication of rifampicin in foals","volume":"39","author":"Peters","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088922_bib32","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cbi.2005.11.001","article-title":"Metabolism and transporter-mediated drug-drug interactions of the endothelin-A receptor antagonist CI-1034","volume":"159","author":"Sahi","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.119.088922_bib33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1124\/jpet.116.232066","article-title":"Coproporphyrins I and III as functional markers of OATP1B activity: in vitro and in vivo evaluation in preclinical species","volume":"357","author":"Shen","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.088922_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1124\/jpet.112.200691","article-title":"Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in vitro, in vivo, and in vitro-to-in vivo extrapolation","volume":"344","author":"Shen","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.119.088922_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jhep.2009.11.012","article-title":"Liver disease associated with canalicular transport defects: current and future therapies","volume":"52","author":"Stapelbroek","year":"2010","journal-title":"J Hepatol"},{"key":"10.1124\/dmd.119.088922_bib36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3109\/00498259009046832","article-title":"Autoinduction of rifabutin metabolism in man","volume":"20","author":"Strolin Benedetti","year":"1990","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.119.088922_bib37","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1124\/mol.104.007161","volume":"67","author":"Sugatani","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.119.088922_bib38","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1124\/dmd.113.052753","article-title":"Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys","volume":"41","author":"Takahashi","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088922_bib39","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.addr.2010.08.006","article-title":"Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR","volume":"62","author":"Tolson","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.119.088922_bib40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2017.05.014","article-title":"Molecular properties associated with transporter-mediated drug disposition","volume":"116","author":"Varma","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/dmd.119.088922_bib41","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm Res"},{"key":"10.1124\/dmd.119.088922_bib42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/dmd.115.065581","article-title":"Evaluation of normalization methods to predict CYP3A4 induction in six fully characterized cryopreserved human hepatocyte preparations and HepaRG cells","volume":"44","author":"Vermet","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.119.088922_bib43","doi-asserted-by":"crossref","first-page":"e74425","DOI":"10.1371\/journal.pone.0074425","article-title":"Development of novel rifampicin-derived P-glycoprotein activators\/inducers, synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate","volume":"8","author":"Vilas-Boas","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/dmd.119.088922_bib44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijantimicag.2013.01.004","article-title":"Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro","volume":"41","author":"Weiss","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1124\/dmd.119.088922_bib45","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1128\/AAC.01124-13","article-title":"Induction of influx and efflux transporters and cytochrome P450 3A4 in primary human hepatocytes by rifampin, rifabutin, and rifapentine","volume":"57","author":"Williamson","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/dmd.119.088922_bib46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13238-013-0013-0","article-title":"Signaling control of the constitutive androstane receptor (CAR)","volume":"5","author":"Yang","year":"2014","journal-title":"Protein Cell"},{"key":"10.1124\/dmd.119.088922_bib47","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/cts.12625","article-title":"Organic anion transporter polypeptide 1B1 polymorphism modulates the extent of drug-drug interaction and associated biomarker levels in healthy volunteers","volume":"12","author":"Yee","year":"2019","journal-title":"Clin Transl Sci"},{"key":"10.1124\/dmd.119.088922_bib48","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1208\/s12248-009-9106-3","article-title":"Predicting drug-drug interactions: an FDA perspective","volume":"11","author":"Zhang","year":"2009","journal-title":"AAPS J"},{"key":"10.1124\/dmd.119.088922_bib49","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0149-2918(08)80052-5","article-title":"Pharmacokinetics of rosuvastatin when coadministered with rifampicin in healthy males: a randomized, single-blind, placebo-controlled, crossover study","volume":"30","author":"Zhang","year":"2008","journal-title":"Clin Ther"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624077894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.119.088922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:23:16Z","timestamp":1739956996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624077894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0090955624077894"],"URL":"https:\/\/doi.org\/10.1124\/dmd.119.088922","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic Anion-Transporting Polypeptide Genes Are Not Induced by the Pregnane X Receptor Activator Rifampin: Studies in Hepatocytes In Vitro and in Monkeys In Vivo","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.119.088922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}